Triple

T22871259
Position Surface form Disambiguated ID Type / Status
Subject CYP2C9 E567200 entity
Predicate metabolizes P37221 FINISHED
Object losartan NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: losartan | Statement: [CYP2C9, metabolizes, losartan]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: losartan
Context triple: [CYP2C9, metabolizes, losartan]
  • A. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • B. Verapaz
    Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
  • C. Atalide
    Atalide is a central tragic heroine in Jean Racine’s 1672 play "Bajazet," caught in a complex web of love, jealousy, and political intrigue in the Ottoman court.
  • D. Renagel
    Renagel is a prescription phosphate-binding medication (sevelamer hydrochloride) used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
  • E. Brilique
    Brilique is a brand name for the antiplatelet medication ticagrelor, used to reduce the risk of cardiovascular events such as heart attacks and strokes in patients with acute coronary syndromes or a history of myocardial infarction.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: losartan
Target entity description: Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed to treat high blood pressure and protect kidney function, particularly in patients with diabetes.
  • A. Entresto
    Entresto is a prescription heart failure medication that combines sacubitril and valsartan to reduce the risk of cardiovascular death and hospitalization.
  • B. Verapaz
    Verapaz is a historical region in Guatemala known for its highland terrain, indigenous Maya communities, and colonial-era missionary history.
  • C. Atalide
    Atalide is a central tragic heroine in Jean Racine’s 1672 play "Bajazet," caught in a complex web of love, jealousy, and political intrigue in the Ottoman court.
  • D. Renagel
    Renagel is a prescription phosphate-binding medication (sevelamer hydrochloride) used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
  • E. Brilique
    Brilique is a brand name for the antiplatelet medication ticagrelor, used to reduce the risk of cardiovascular events such as heart attacks and strokes in patients with acute coronary syndromes or a history of myocardial infarction.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e24589d8348190b96422d13a678bc1 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17f05c688819097ba3d24ea8e52f5 completed April 29, 2026, 3:46 a.m.
Created at: April 17, 2026, 3:38 p.m.